company background image
300246 logo

Guangdong Biolight Meditech SZSE:300246 Stock Report

Last Price

CN¥6.15

Market Cap

CN¥1.6b

7D

1.2%

1Y

-49.8%

Updated

10 Aug, 2024

Data

Company Financials +

Guangdong Biolight Meditech Co., Ltd.

SZSE:300246 Stock Report

Market Cap: CN¥1.6b

300246 Stock Overview

Engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions.

300246 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 300246 from our risk checks.

Guangdong Biolight Meditech Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guangdong Biolight Meditech
Historical stock prices
Current Share PriceCN¥6.15
52 Week HighCN¥12.61
52 Week LowCN¥5.07
Beta0.30
11 Month Change4.41%
3 Month Change-17.23%
1 Year Change-49.75%
33 Year Change-44.43%
5 Year Change-25.42%
Change since IPO-23.50%

Recent News & Updates

Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)

Jun 07
Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)

Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge

Jun 06
Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge

Recent updates

Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)

Jun 07
Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)

Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge

Jun 06
Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge

There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise

Mar 08
There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise

Shareholder Returns

300246CN Medical EquipmentCN Market
7D1.2%0.4%-1.6%
1Y-49.8%-15.2%-19.6%

Return vs Industry: 300246 underperformed the CN Medical Equipment industry which returned -15.2% over the past year.

Return vs Market: 300246 underperformed the CN Market which returned -19.6% over the past year.

Price Volatility

Is 300246's price volatile compared to industry and market?
300246 volatility
300246 Average Weekly Movement5.1%
Medical Equipment Industry Average Movement5.1%
Market Average Movement5.7%
10% most volatile stocks in CN Market9.0%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 300246's share price has been volatile over the past 3 months.

Volatility Over Time: 300246's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19931,419Jinyuan Yanwww.blt.com.cn

Guangdong Biolight Meditech Co., Ltd. engages in the research and development, marketing, sale, and service of medical devices, medical consumables, and healthcare solutions. The company offers patient monitors, ECG monitoring equipment, fetal monitors, hemodialysis products, medical products, monitors, and accessories. It operates in Asia, Africa, Europe, North America, and Latin America.

Guangdong Biolight Meditech Co., Ltd. Fundamentals Summary

How do Guangdong Biolight Meditech's earnings and revenue compare to its market cap?
300246 fundamental statistics
Market capCN¥1.62b
Earnings (TTM)-CN¥88.72m
Revenue (TTM)CN¥1.12b

1.5x

P/S Ratio

-18.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300246 income statement (TTM)
RevenueCN¥1.12b
Cost of RevenueCN¥793.93m
Gross ProfitCN¥322.37m
Other ExpensesCN¥411.09m
Earnings-CN¥88.72m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 29, 2024

Earnings per share (EPS)-0.34
Gross Margin28.88%
Net Profit Margin-7.95%
Debt/Equity Ratio48.2%

How did 300246 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.